Brainstorm Cell Therapeutics In - stock earnings
BCLI Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -1.2 million USD | ? USD |
| 2023Q2 | -5.3 million USD | 154000 USD |
| 2023Q1 | -5.0 million USD | -497000 USD |
| 2022Q4 | -5.1 million USD | ? USD |
| 2022Q3 | -6.9 million USD | 474000 USD |
| 2022Q2 | -6.5 million USD | 204000 USD |
| 2022Q1 | -5.1 million USD | 340000 USD |
| 2021Q4 | -6.2 million USD | ? USD |
| 2021Q3 | -5.3 million USD | ? USD |
| 2021Q2 | -6.3 million USD | 87000 USD |
| 2021Q1 | -6.7 million USD | 501000 USD |
| 2020Q4 | -11.8 million USD | ? USD |
| 2020Q3 | -4.5 million USD | ? USD |
| 2020Q2 | -7.4 million USD | 823000 USD |
| 2020Q1 | -8.1 million USD | ? USD |
| 2019Q4 | -7.7 million USD | -366000 USD |
| 2019Q3 | -5.6 million USD | 1.0 million USD |
| 2019Q2 | -4.9 million USD | ? USD |
| 2019Q1 | -5.0 million USD | ? USD |
| 2018Q4 | -5.4 million USD | 170000 USD |
| 2018Q3 | -3.2 million USD | -1.0 million USD |
| 2018Q2 | -3.1 million USD | 57000 USD |
| 2018Q1 | -2.3 million USD | ? USD |
| 2017Q4 | 276000 USD | 975000 USD |
| 2017Q3 | -2.4 million USD | 131000 USD |
| 2017Q2 | -1.0 million USD | ? USD |
| 2017Q1 | -1.8 million USD | ? USD |
| 2016Q4 | -624000 USD | 212000 USD |
| 2016Q3 | -1.6 million USD | ? USD |
| 2016Q2 | -962000 USD | ? USD |
| 2016Q1 | -1.8 million USD | ? USD |
| 2015Q4 | -1.4 million USD | 467000 USD |
| 2015Q3 | -2.6 million USD | 732000 USD |
| 2015Q2 | -2.3 million USD | -33000 USD |
| 2015Q1 | -2.2 million USD | 177000 USD |
| 2014Q4 | -2.7 million USD | ? USD |
| 2014Q3 | -2.4 million USD | 66000 USD |
| 2014Q2 | -2.0 million USD | ? USD |
| 2014Q1 | -2.1 million USD | ? USD |
| 2013Q4 | -1.2 million USD | ? USD |
| 2013Q3 | -1.1 million USD | ? USD |
| 2013Q2 | -1.5 million USD | ? USD |
| 2013Q1 | -1.1 million USD | ? USD |
| 2012Q4 | -579000 USD | ? USD |
| 2012Q3 | -1.2 million USD | ? USD |
| 2012Q2 | -830000 USD | ? USD |
| 2012Q1 | -872000 USD | ? USD |
| 2011Q4 | -1.4 million USD | ? USD |
| 2011Q3 | -694000 USD | ? USD |
| 2011Q2 | -1.1 million USD | ? USD |
| 2011Q1 | -705000 USD | ? USD |
| 2010Q4 | -486000 USD | ? USD |
| 2010Q3 | -704000 USD | ? USD |
| 2010Q2 | -614000 USD | ? USD |
| 2010Q1 | -615000 USD | ? USD |
| 2009Q4 | -103000 USD | ? USD |
| 2009Q3 | -621000 USD | ? USD |
| 2009Q2 | -543000 USD | ? USD |
| 2009Q1 | -626000 USD | ? USD |
| 2008Q4 | -626000 USD | ? USD |
| 2008Q3 | -728000 USD | ? USD |
| 2008Q2 | -856000 USD | ? USD |
| 2008Q1 | -1.9 million USD | ? USD |
| 2007Q4 | -1.9 million USD | ? USD |
| 2007Q3 | -1.5 million USD | ? USD |
| 2007Q2 | -1.2 million USD | ? USD |
| 2007Q1 | -1.7 million USD | ? USD |
| 2006Q4 | -804176 USD | ? USD |
| 2006Q3 | -1.0 million USD | ? USD |
| 2006Q2 | -849420 USD | ? USD |
| 2006Q1 | -614949 USD | ? USD |
| 2005Q4 | -923887 USD | ? USD |
| 2005Q3 | -1.0 million USD | ? USD |
| 2005Q2 | -739788 USD | ? USD |
| 2005Q1 | -563458 USD | ? USD |
| 2004Q4 | -16.7 million USD | ? USD |
| 2004Q3 | -1.6 million USD | ? USD |
| 2004Q2 | 20866 USD | ? USD |
| 2004Q1 | -35785 USD | ? USD |
| 2003Q4 | -14598 USD | ? USD |
| 2003Q3 | -11037 USD | ? USD |
| 2003Q2 | -11875 USD | ? USD |
| 2003Q1 | -16488 USD | ? USD |
| 2002Q4 | -13531 USD | 70389 USD |
| 2002Q3 | -8176 USD | 12500 USD |
| 2002Q2 | -8611 USD | ? USD |
BCLI Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -16.6 million USD | ? USD |
| 2022 | -23.7 million USD | ? USD |
| 2021 | -24.4 million USD | ? USD |
| 2020 | -31.9 million USD | ? USD |
| 2019 | -23.5 million USD | -366000 USD |
| 2018 | -13.8 million USD | ? USD |
| 2017 | -5.0 million USD | ? USD |
| 2016 | -5.0 million USD | ? USD |
| 2015 | -8.5 million USD | ? USD |
| 2014 | -9.2 million USD | ? USD |
| 2013 | -4.9 million USD | ? USD |
| 2012 | -3.4 million USD | ? USD |
| 2011 | -3.9 million USD | ? USD |
| 2010 | -2.4 million USD | ? USD |
| 2009 | -1.8 million USD | ? USD |
| 2008 | -3.5 million USD | ? USD |
| 2007 | -6.2 million USD | ? USD |
| 2006 | -3.9 million USD | ? USD |
| 2005 | -3.3 million USD | ? USD |
| 2004 | -18.8 million USD | ? USD |
| 2003 | -73295 USD | ? USD |
| 2002 | -46806 USD | 82889 USD |
| 2001 | -25560 USD | 22900 USD |
BCLI
Price: $0.38
52 week price:
Earnings Per Share: -0.42 USD
P/E Ratio: -0.92
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 566900
Ebitda: -2.4 millionMarket Capitalization: 28.3 million